Ovarian cancer: an overview
- PMID: 19817326
Ovarian cancer: an overview
Abstract
Although ovarian cancer may occur at any age, it is more common in patients older than 50 years. Patients often present with nonspecific pelvic or abdominal symptoms. Initial diagnostic tests include transvaginal ultrasonography and serum cancer antigen 125 measurement; however, these tests are not specific for ovarian cancer. Conventional treatment includes surgical debulking followed by chemotherapy. Prognosis is typically determined by the cancer stage and grade, although future treatment may depend on tumor genetic composition. Epithelial ovarian cancer is the most common type of ovarian cancer, and because 70 percent of cases are diagnosed at stage III or IV, it is associated with a poor prognosis. Preventive visits provide an opportunity to identify and educate women at increased risk of ovarian cancer, but routine screening is not recommended. Women with a family history of ovarian cancer or a known associated genetic syndrome should be offered genetic counseling or a discussion of available preventive interventions, respectively.
Similar articles
-
The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.J Cancer Res Clin Oncol. 2002 Mar;128(3):153-60. doi: 10.1007/s00432-001-0312-3. Epub 2002 Jan 29. J Cancer Res Clin Oncol. 2002. PMID: 11935302 Review.
-
Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.Clin J Oncol Nurs. 2008 Jun;12(3):445-54. doi: 10.1188/08.CJON.445-454. Clin J Oncol Nurs. 2008. PMID: 18515243 Review.
-
A comprehensive look at the early detection of ovarian cancer.Clin J Oncol Nurs. 2003 Jan-Feb;7(1):41-7. doi: 10.1188/03.CJON.41-47. Clin J Oncol Nurs. 2003. PMID: 12629933 Review.
-
Women's awareness of ovarian cancer risks and symptoms.Am J Nurs. 2009 Sep;109(9):36-45; quiz 46. doi: 10.1097/01.NAJ.0000360309.08701.73. Am J Nurs. 2009. PMID: 19704232
-
[Current status of the management of patients with malignant ovarian cancer in Hungary].Orv Hetil. 1997 Feb 16;138(7):405-11. Orv Hetil. 1997. PMID: 9091841 Review. Hungarian.
Cited by
-
Prognostic significance of non-coding RNAs related to the tumorigenic epithelial-mesenchymal transition (EMT) process among ovarian cancer patients: A systematic review and meta-analysis.Heliyon. 2024 Aug 8;10(16):e35202. doi: 10.1016/j.heliyon.2024.e35202. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253159 Free PMC article.
-
The Presence of Ovarian Cancer and the Incidence of Subsequent Open-Angle Glaucoma: A Population-Based Cohort Study.Cancers (Basel). 2024 Aug 12;16(16):2828. doi: 10.3390/cancers16162828. Cancers (Basel). 2024. PMID: 39199599 Free PMC article.
-
Infrastructural and public health awareness gaps for the diagnosis and treatment of ovarian cancer: A literature review.Arch Gynecol Obstet. 2024 May;309(5):1807-1813. doi: 10.1007/s00404-024-07371-y. Epub 2024 Feb 28. Arch Gynecol Obstet. 2024. PMID: 38413425 Review.
-
PRR11 in Malignancies: Biological Activities and Targeted Therapies.Biomolecules. 2022 Dec 1;12(12):1800. doi: 10.3390/biom12121800. Biomolecules. 2022. PMID: 36551227 Free PMC article. Review.
-
One-Step Electrochemical Sensing of CA-125 Using Onion Oil-Based Novel Organohydrogels as the Matrices.ACS Omega. 2024 Apr 8;9(16):17919-17930. doi: 10.1021/acsomega.3c09149. eCollection 2024 Apr 23. ACS Omega. 2024. PMID: 38680375 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical